Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Areata (AA)”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Study completedNCT02018042
What this trial is testing

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Who this might be right for
Alopecia Areata
Columbia University 15
Not applicableNot Yet RecruitingNCT07226531
What this trial is testing

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Who this might be right for
Alopecia Areata
Pfizer 300
Not applicableLooking for participantsNCT06562270
What this trial is testing

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Who this might be right for
Alopecia Areata
CorEvitas 1,500
Early research (Phase 1)Looking for participantsNCT06799520
What this trial is testing

Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Alopecia Areata (AA)Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT05551793
What this trial is testing

Regeneron AA Multicenter (Dupilumab)

Who this might be right for
Alopecia Areata
Emma Guttman 68
Testing effectiveness (Phase 2)Study completedNCT06402630
What this trial is testing

Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)

Who this might be right for
Alopecia Areata
Soterios Ltd 158
Early research (Phase 1)Looking for participantsNCT06602232
What this trial is testing

DR-01 in Subjects With Alopecia Areata and Vitiligo

Who this might be right for
Alopecia AreataVitiligo
Dren Bio 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Large-scale testing (Phase 3)Looking for participantsNCT07023302
What this trial is testing

Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia Areata

Who this might be right for
Alopecia Areata
AbbVie 123
Early research (Phase 1)Looking for participantsNCT07049328
What this trial is testing

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

Who this might be right for
Alopecia Areata(AA)
HCW Biologics 30
Not applicableStudy completedNCT05594316
What this trial is testing

New Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Al-Azhar University 40
Not applicableLooking for participantsNCT06531109
What this trial is testing

Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib

Who this might be right for
Alopecia Areata
Pfizer 850
Post-approval studies (Phase 4)Looking for participantsNCT07381556
What this trial is testing

Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

Who this might be right for
Alopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/Universalis+3 more
Erasmus Medical Center 50
Not applicableAvailableNCT05522556
What this trial is testing

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Who this might be right for
Alopecia Areata
Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT06340360
What this trial is testing

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)

Who this might be right for
Alopecia Areata
Nektar Therapeutics 94
Not applicableLooking for participantsNCT05745389
What this trial is testing

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Who this might be right for
Alopecia Areata
CorEvitas 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04445363
What this trial is testing

A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata

Who this might be right for
Alopecia Areata(AA)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 160
Testing effectiveness (Phase 2)Looking for participantsNCT06826196
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata

Who this might be right for
Alopecia Areata (AA)
Aldena Therapeutics 24
Early research (Phase 1)Study completedNCT05650333
What this trial is testing

Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age

Who this might be right for
Alopecia Areata
Pfizer 15
Testing effectiveness (Phase 2)Ended earlyNCT03759340
What this trial is testing

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia AreataAlopecia UniversalisAlopecia Totalis
Aclaris Therapeutics, Inc. 56
Load More Results